Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156533 · ClinicalTrials.gov registry record · Phase 4
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00156533 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 20 participants.
The verdict
NCT00156533, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.
Interventions
- DRUG Zolpidem
- DRUG Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156533
The ClinicalTrials.gov registry entry for NCT00156533 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zolpidem is the first listed.
NCT00156533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00156533 about?
NCT00156533 is a clinical study titled "Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing". We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.
What is the current status of trial NCT00156533?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-03. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00156533?
The interventions under investigation include: Zolpidem (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT00156533?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.